English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jun 11, 2026

Genentech restructures R&D group, longtime executive among departures
+ Pharmaceuticals
Patient Daily | Jun 11, 2026

Study finds Chile’s food regulations reduce obesity risk among schoolchildren
+ Pharmaceuticals
Patient Daily | Jun 11, 2026

Kurraba Group announces first partners for ION life sciences precinct in Sydney
+ Pharmaceuticals
Patient Daily | Jun 11, 2026

Niowave begins construction of $75 million radioisotope facility in Lansing
+ Pharmaceuticals
Patient Daily | Jun 11, 2026

REGENXBIO, Novartis and Dyne prepare for FDA submissions in muscular dystrophy treatments
+ Pharmaceuticals
Patient Daily | Jun 10, 2026

New biotech alliance forms to strengthen U.S. innovation amid competition with China
+ Pharmaceuticals
Patient Daily | Jun 10, 2026

Disc Medicine to resubmit rare blood disorder drug after FDA meeting
+ Pharmaceuticals
Patient Daily | Jun 10, 2026

NIH awards $1 million grant to study genetics of pediatric cataracts

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation